SCHEMBL19334516

SCHEMBL19334516

O=C(Nc1nc2ccccc2s1)c1ccc(Cl)c([N+](=O)O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.63
NPC1 O15118 8/20 0.61
RAB9A P51151 8/20 0.61
MEN1 O00255 8/20 0.61
KMT2A Q03164 8/20 0.61
SMN1; SMN2 Q16637 4/20 0.61
SCD O00767 5/20 0.61
MMP13 P45452 1/20 0.61
KDM4E B2RXH2 5/20 0.59
HTT P42858 2/20 0.59
NFKB1 P19838 2/20 0.59
NFKB2 Q00653 2/20 0.59
RELA Q04206 2/20 0.59
DHODH Q02127 3/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MAPT P10636 2/20 0.57
LMNA P02545 2/20 0.57
ALDH1A1 P00352 1/20 0.57
MAPK1 P28482 1/20 0.57
GPR35 Q9HC97 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4910888 0.90 KMT2A (0.71) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL4917465 0.87 TOP1 (0.70) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL30576828 0.81 TOP1 (0.66) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL26606518 0.81 TOP1 (0.66) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL30553332 0.80 NPC1 (0.78) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL4920234 0.79 SCD (0.73) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL14807588 0.79 TOP1 (0.74) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL4918578 0.78 SCD (0.69) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL3053529 0.77 NPC1 (1.00) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL5732423 0.76 SCD (0.69) TOP1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9757375-B2 Compounds that inhibit human DNA ligases and methods of treating cancer UNIVERSITY OF MARYLAND, BALTIMORE (US) 2017-09-12 US disclosed